 |
|
|
| |
Evaluation of Ritonavir-boosted Elvitegravir PK upon Co-administration with a Second Potent CYP3A inhibitor, Ketoconazole
|
| |
| |
Reported by Jules Levin
International Workshop on Clinical Pharmacology of HIV Therapy April 7-9, 2010 Sorrento, Italy
P. German, AA Mathias, S West, S Chuck, BP Kearney
Gilead Sciences, Inc., Foster City, CA 94404
|
| |
|
|
|
|
|
